Leerink Partnrs dropped their Q2 2025 EPS estimates for Cencora in a report released on Wednesday, February 5th. Leerink Partnrs analyst M. Cherny now forecasts that the company will earn $4.08 per ...
Walgreens has sold more shares of drug distributor Cencora for proceeds of about $300 million in the latest effort to pay ...
Walgreens Boots Alliance, Inc. (NASDAQ:WBA), through its subsidiary Walgreens Boots Alliance Holdings LLC, recently reported significant stock transactions involving Cencora, Inc. (NYSE:COR), a ...
U.S. drugstore chain Walgreens Boots Alliance said on Thursday it has sold more shares in drug distributor Cencora for ...
Over the past year, many Cencora, Inc. ( NYSE:COR ) insiders sold a significant stake in the company which may ...
Shares of Cencora Inc. COR slid 2.82% to $246.13 Thursday, on what proved to be an all-around mixed trading session for the ...
The sale netted about $300 million for Walgreens and shrinks the company’s stake in Cencora to approximately 6%, down from 10 ...
Cencora, Inc (NYSE:COR) reported first-quarter 2025 sales increased 12.8% to $81.5 billion, beating the consensus of $78.38 ...
Cencora (COR) has significantly expanded the number and type of medications available in its sure supply program, a drug shortage mitigation ...
Shares of Cencora Inc. COR shed 1.12% to $251.57 Tuesday, on what proved to be an all-around positive trading session for the ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback